As one of the largest and most comprehensive events in pharmaceutical drugs industry, CPhI India was held from November 28^th to November 30^th, 2017 at the Bombay Exhibition Centre in Mumbai, India.

I. Of the exhibitors, 25% were from China.

CPhI India is one of the largest and most comprehensive pharmaceutical industry events in South Asia, focusing on pharmaceutical ingredients, machinery, equipment, outsourcing and bio-solutions for the pharmaceutical industry.

CPhI India has attracted high-quality prospectors who are actively looking for these pharmaceutical products and services since its inception in 2006. Given the low barrier of market entry, it has gained attention from all over the world, especially from Chinese API manufacturers and traders.

The exhibition attracted over 1,200 exhibitors, half of which were small and medium-sized companies. As indicated by the chart, 40% of them were from India, 25% from China and 10% from Europe and America.

There was a good flow of people and over 25,000 visitors attended the exhibition of whom most were manufacturers and traders from South Asian regions such as India, Pakistan and Bangladesh.

II. Indian suppliers are bullish on  Chinese market.

According to statistics, India is the world’s third largest producer of generic drugs, producing 20% of global generic drugs.

Thus, exhibits were mainly low-end APIs with very few high-end and innovative drugs.

In regards to the Chinese market, it was found that the demands of pharmaceutical suppliers and buyers in India are somewhat different to that of the local Chinese market.

III. Ddu at CPhI India

This was the second time Ddu attended CPhI India. Due to Ddu’s well-established reputation among foreign clients, numerous visitors flocked to the Ddu booth for consultation.

Sanjay Rastogi, Chief marking director of Peacock Medicine

Sanjay Rastogi, Chief marking director of Peacock Medicine, a local service provider, praised Ddu’s attentive services, stating that Ddu allowed them to gain access to products with FDA approval which holds exciting prospects for the future.

Mr. Sahu, associate vice president of Wockhardt

Mr. Sahu, associate vice president of Wockhardt, India's fourth largest multinational pharmaceutical group, raved about Ddu’s industry chain solutions for the cross-border medical trade.

IV. Thank you to users for their support and trust in Ddu.

As the three-day exhibition came to an end, so did the Ddu Global Promotion Plan for 2017.

During 2017, Ddu travelled to numerous professional exhibitions in the US, Germany, India Japan to mention but a few. This boosted over ten thousand business deals and gained great attention from thousands of professionals in the industry.

All these efforts were focused on facilitating the cross-border medical trade, making it more accessible to people across the globle. Your support and trust in Ddu is sincerely appreciated.

2018 is expected to be a big year as more and more users continuously join Ddu and find their pharmaceutical products. We look forward to the change it will bring!